Article Listing - Solid Third Quarter At SB Thanks To New Products

VARIED FORTUNES FOR COLD REMEDIES

9 March 1992

As far as cold remedies in European markets are concerned, 1991 was a year of mixed fortunes. In some, the...

JAPANESE PHARMA INDUSTRY DATA BOOK 1991

9 March 1992

There was a total of 1,532 pharmaceutical manufacturers in Japan in 1989 compared with 1,359 in 1975, and of these,...

FRENCH PHARMACY MONOPOLY ROW

9 March 1992

A new round of skirmishes has begun on the French drug "frontier" - the controversial legal borderline that separates drugs,...

ZOVIRAX ENDORSED FOR CHICKENPOX

9 March 1992

The US Food and Drug Administr-ation has granted Burroughs Wellcome approval to market its antiviral product Zovirax (aciclovir) as an...

US GOVT "CONCERN" OVER JAPANESE REG MOVES

9 March 1992

The US Department of Commerce in late February officially notified Japan's Ministry of Health and Welfare of its concerns over...

EC PRICE CONTROLS "DO NOT WORK"

9 March 1992

A draft recommendation is currently being circulated for comment by the Commission of the European Comunity, seeking to amend the...

MAbs MAY PROVIDE MS TREATMENT

9 March 1992

A research project carried out by scientists from Athena Neurosci-ences in collaboration with Stanford University of California, USA, and the...

FISONS' US DIFFICULTIES BRING PROFIT DOWN 17%

9 March 1992

Despite a new openness being embarked upon at Fisons since Patrick Egan took over as chairman following the resignation of...

SB'S GEORGE POSTE

9 March 1992

George Poste, chairman of R&D at SmithKline Beecham Pharmaceuticals, has been elected an executive director of Smith-Kline Beecham plc.

TLC'S MICHAEL BEVILACQUA

9 March 1992

The Liposome Company Inc has announced the appointment of Michael Bevilacqua as a member of its Cell Adhesion Scientific Advisory...

Showing 94741-94750 of 95376 articles

Go to beginningPreviousNextGo to end